American Strategic Investment Co. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that American Strategic Investment Co. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $700.0K | Mar 19, 2025 |
| FY2022 | Dec 31, 2022 | $16.20M | Mar 16, 2023 |
| FY2022 | Sep 30, 2022 | $15.93M | Mar 16, 2023 |
| FY2022 | Jun 30, 2022 | $16.23M | Mar 16, 2023 |
| FY2022 | Mar 31, 2022 | $15.65M | Mar 16, 2023 |
| FY2021 | Sep 30, 2021 | $300.0K | Mar 18, 2022 |
| FY2020 | Dec 31, 2020 | $9.86M | Mar 29, 2021 |
| FY2020 | Sep 30, 2020 | $17.00M | Mar 29, 2021 |
| FY2020 | Jun 30, 2020 | $18.56M | Mar 29, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($21.19M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($140.59M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | ($105.92M) | Apr 15, 2026 |
| FY2022 | Dec 31, 2022 | ($10.11M) | Mar 16, 2023 |
| FY2022 | Sep 30, 2022 | ($11.07M) | Mar 16, 2023 |
| FY2022 | Jun 30, 2022 | ($13.00M) | Mar 16, 2023 |
| FY2022 | Mar 31, 2022 | ($11.71M) | Mar 16, 2023 |
| FY2023 | Dec 31, 2021 | ($39.47M) | Apr 1, 2024 |
| FY2020 | Dec 31, 2020 | ($16.60M) | Mar 29, 2021 |
| FY2020 | Sep 30, 2020 | ($12.29M) | Mar 29, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.40M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($121.22M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | ($87.10M) | Apr 15, 2026 |
| FY2022 | Dec 31, 2022 | ($5.36M) | Mar 16, 2023 |
| FY2022 | Sep 30, 2022 | ($6.32M) | Mar 16, 2023 |
| FY2022 | Jun 30, 2022 | ($8.30M) | Mar 16, 2023 |
| FY2022 | Mar 31, 2022 | ($6.96M) | Mar 16, 2023 |
| FY2023 | Dec 31, 2021 | ($20.39M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | ($22.61M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | ($5.58M) | Mar 18, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.75M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($4.00M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | ($7.41M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2022 | ($486.0K) | Mar 19, 2025 |
| FY2023 | Dec 31, 2021 | ($7.92M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | ($13.58M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | ($1.60M) | Mar 18, 2022 |
| FY2020 | Dec 31, 2018 | ($7.08M) | Mar 29, 2021 |
| FY2019 | Dec 31, 2017 | $2.28M | Mar 19, 2020 |
| FY2018 | Dec 31, 2016 | $4.13M | Mar 15, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $445.16M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $507.07M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $694.17M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $790.46M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $823.05M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $861.85M | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | $901.36M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $773.74M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $760.45M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $773.60M | Jun 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $380.40M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $421.48M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $469.38M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $468.88M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $471.92M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $480.28M | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | $480.81M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $330.06M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $278.97M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $233.41M | Jun 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.76M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $85.59M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $224.79M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $301.06M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $338.99M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $377.56M | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | $420.55M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $443.68M | Mar 19, 2020 |
| FY2019 | Dec 31, 2017 | $481.48M | Mar 19, 2020 |
| FY2019 | Dec 31, 2016 | $540.19M | Mar 19, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($667.06M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($645.87M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($505.28M) | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | ($399.36M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($350.71M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | ($305.88M) | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | ($264.28M) | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($242.39M) | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | ($210.61M) | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | ($140.60M) | Jun 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.30M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $9.78M | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | $5.29M | Apr 15, 2026 |
| FY2024 | Dec 31, 2022 | $9.22M | Mar 19, 2025 |
| FY2023 | Dec 31, 2021 | $11.67M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $31.00M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $51.20M | Mar 18, 2022 |
| FY2020 | Dec 31, 2018 | $47.95M | Mar 29, 2021 |
| FY2018 | Dec 31, 2017 | $39.60M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $47.67M | Jun 8, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (8) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (56) | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | (47) | Apr 15, 2026 |
| FY2022 | Dec 31, 2022 | (5) | Mar 16, 2023 |
| FY2022 | Sep 30, 2022 | (6) | Mar 16, 2023 |
| FY2022 | Jun 30, 2022 | (7) | Mar 16, 2023 |
| FY2022 | Mar 31, 2022 | (7) | Mar 16, 2023 |
| FY2023 | Dec 31, 2021 | (24) | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | (25) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Mar 18, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (8) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (56) | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | (47) | Apr 15, 2026 |
| FY2022 | Dec 31, 2022 | (5) | Mar 16, 2023 |
| FY2022 | Sep 30, 2022 | (6) | Mar 16, 2023 |
| FY2022 | Jun 30, 2022 | (7) | Mar 16, 2023 |
| FY2022 | Mar 31, 2022 | (7) | Mar 16, 2023 |
| FY2023 | Dec 31, 2021 | (24) | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | (25) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Mar 18, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.69M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 2.63M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 2.33M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | 1.89M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 1.66M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 12.80M | Mar 18, 2022 |
| FY2020 | Dec 31, 2019 | 12.76M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | 30.99M | Mar 19, 2020 |
| FY2020 | Jul 24, 2018 | 210,014 | Mar 29, 2021 |
| FY2020 | Jun 15, 2018 | 500,000 | Mar 29, 2021 |